Rate My Professor Kurt Krause

His research centers on the structural biology of proteins critical to infectious diseases, encompassing bacterial pathogenesis factors, antibiotic resistance targets—particularly in tuberculosis—viral immunomodulatory proteins, and bioluminescence-associated proteins such as those in New Zealand glowworms. Key contributions include structural studies enabling vaccine and therapeutic development for pathogens like norovirus, coronavirus, and Mycobacterium tuberculosis. Recent publications feature "Broad-spectrum peptidomimetic inhibitors of norovirus and coronavirus 3C-like proteases" (Brimble et al., 2026, ACS Infectious Diseases), "Advancing the antituberculosis activity of nitropicolinic acids and amides" (Thompson et al., 2025, European Journal of Medicinal Chemistry), "Activity and cryo-EM structure of the polymerase domain of the human norovirus ProPol precursor" (McSweeney et al., 2024, Journal of Virology), "Dual transcriptional inhibition of glutamate and alanine racemase is synergistic in Mycobacterium tuberculosis" (McNeil et al., 2024, Microbiology), and "Targeting tuberculosis: Novel scaffolds for inhibiting cytochrome bd oxidase" (Seitz et al., 2024, Journal of Chemical Information & Modeling). He has secured funding from the Royal Society Te Apārangi Catalyst Fund (2017) and Health Research Council Programme Grants for tuberculosis research (2023).